Connecting People & Ideas to Advance Mutual Interests in U.S.-Asia Relations

In the third exchange, participants traveled to Washington, D.C., Philadelphia, and Boston in September 2015. In Washington they met with policy and regulatory affairs experts from pharmaceutical companies, the Brookings Institution, and the U.S. House of Representatives Science Committee. They also visited the U.S. Food and Drug Administration and participated in meetings and a lab tour at the National Institutes of Health, National Center for Advancing Translational Sciences. In Philadelphia they visited the University of Pennsylvania Institute for Translational Medicine and Therapeutic. In Boston their visits included the Tufts Center for the Study of Drug Development, Harvard Catalyst/The Harvard Clinical and Translational Science Center, UMass Center for Clinical and Translational Science, and the Broad Institute. The researchers also met with experts in major pharmaceutical research and development programs.

On the last day of the September 2015 exchange, the researchers gathered in Boston for a wrap-up session to discuss points they thought were important for Japan. They wrote the points on sticky notes, prioritized them, and selected がんばれ日本!(Go for it, Japan!) as the point that summarizes their conclusion that there are many things Japan must do to better the current situation to promote translational research. Their message is intended to encourage Japanese academic researchers, institutions, the Japanese government and others to go forward with this shared mission.